This service is available Mon-Fri from 8am-6pm Mtn Time.
The Vioxx®, Celebrex®, and Bextra® attorneys at the Salt Lake City, Utah-area firm of Siegfried & Jensen offer free legal advice and case evaluations for dangerous drug claims. Contact our law office today.
Siegfried & Jensen
5664 South Green St.
Murray, Utah 84123
Phone: 1-866-883-5350
Fax: 1-801-266-1338
Our Vioxx®, Celebrex®, and Bextra® attorneys serving Salt Lake City and all of Utah have extensive experience with cases involving defective drug litigation. The legal experts at the office of Siegfried & Jensen will evaluate your case free of charge. These skilled attorneys will then help you file a claim to obtain the compensation you deserve for your injuries. Our comprehensive contingency fee agreement ensures that if our attorneys are unable to help you obtain a settlement, you will pay us nothing. Visit our pharmaceutical litigation FAQs page for more information about defective and dangerous drug claims.
Vioxx®, Celebrex®, and Bextra® are all members of a class of drugs known as COX-2 inhibitors. COX-2 inhibitors have been prescribed to patients to reduce pain, fever, and inflammation. COX-2 is a receptor responsible for sending pain and inflammation signals to the brain, but it also plays a role in allowing the kidneys to adequately regulate blood pressure. In April 2005 the FDA admitted that COX-2 inhibitors increase the risk of heart attack, stroke, and other cardiovascular problems.
[ back to top ]
The general consensus in the medical community is that the anti-inflammatory benefits of Vioxx® and Bextra® no longer outweigh the risks to a person's life and health. Vioxx® was voluntarily recalled in September of 2004. Since that time there have been over 10,000 individual claims and almost 200 class action lawsuits filed against Merck, the company that manufactured Vioxx®. Due to the severity of Vioxx® side effects many of these cases are classified as wrongful death claims.
In April of 2005 Bextra® was also taken off the market in response to an FDA recommendation for a recall. In addition to the increased risk of heart attack and stroke that accompanies all COX-2 inhibitors, Bextra® users were also at risk of developing a serious and sometimes fatal skin reaction.
If you have been injured by one of these dangerous drugs, our Vioxx® and Bextra® attorneys in the Salt Lake City, Utah area can offer you a free case evaluation to help you determine whether or not you are eligible for compensation. Contact our law office to schedule a time to meet with one of our experienced attorneys today.
[ back to top ]
In April 2005 the FDA required the manufacturer of Celebrex®, the last unrecalled COX-2 inhibitor, to include a black box warning on the drug's label. A black box warning is the strongest warning issued by the FDA without the recommendation of a recall. The Celebrex® black box warning states that use of Celebrex® results in an increased risk of cardiovascular and gastrointestinal problems. Doctors prescribe Celebrex® in the treatment of acute pain caused by osteoarthritis, rheumatoid arthritis, and severe menstrual discomfort. The drug can also be used to decrease the number of pre-cancerous colon and rectum polyps in individuals with an inherited predisposition to polyp development. If you were prescribed Celebrex® prior to April 2005 and have suffered one of more of its side effects you may be eligible for compensation. The Celebrex® attorneys at the Salt Lake City, Utah-area firm of Siegfried & Jensen can assist you in determining whether or not you have a valid Celebrex® claim.
[ back to top ]
Our Vioxx®, Celebrex®, and Bextra® attorneys serving Salt Lake City and the entire state of Utah have the skill and experience to ensure that the drug company respects your right as a patient to be compensated for side effects for which you received inadequate warning. You are not alone in this struggle; thousands of people across the country have been injured by these dangerous drugs. We offer free legal advice and a no-obligation case evaluation. Contact the firm of Siegfried & Jensen today.
[ back to top ]